20 May 2013
Keywords: mmv, gsk, develop, antimalarial, medicines, malaria, venture
Article | 22 November 2004
Medicines for Malaria Venture and UK drug major GlaxoSmithKline have signed an agreement to develop GW844520X, a member of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 November 2004
17 May 2013
© 2013 thepharmaletter.com